Gaucher Disease – An Overview
Year: 2024
Type: article
Abstract: Gaucher disease (GD) is a rare inherited lysosomal storage disorder resulting from mutations in the GBA gene, which encodes the enzyme glucocerebrosidase. This deficiency leads to the accumulation of glucosylceramide within macrophages, forming Gaucher cells and causing diverse clinical manifestations. The disease is classified into three types: Type 1 (non-neuronopathic), Type 2 (acute neuronopathic), and Type 3 (chronic neuronopathic), with Type 1 being the most common. The clinical presentation includes hepatosplenomegaly, anemia, thrombocytopenia, and bone pain, among others. Recent advancements in genetic understanding and therapeutic strategies, such as enzyme replacement therapy (ERT) and substrate reduction therapy (SRT), have improved clinical outcomes. This review focuses on the genetic basis, clinical features, diagnostic strategies, treatment options, and future research directions in Gaucher disease.
Author: Brandl, Edenilson
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6911980051
FWCI:
Cites:
Cited by:
Related to: